Vanda Pharmaceuticals
VNDA
#8815
Rank
ยฃ0.17 B
Marketcap
ยฃ2.83
Share price
-6.42%
Change (1 day)
-13.71%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2026 (TTM): -ยฃ0.14 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are ยฃ0.21 Billion. In 2025 the company made an earning of -ยฃ0.12 Billion a decrease over its 2024 earnings that were of -ยฃ30.4 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ0.14 Billion23.3%
2025 -ยฃ0.12 Billion271.79%
2024 -ยฃ30.4 Million191.43%
2023 -ยฃ10.43 Million-320.45%
2022 ยฃ4.73 M-84.99%
2021 ยฃ31.51 M54.8%
2020 ยฃ20.36 M19.42%
2019 ยฃ17.04 M4.93%
2018 ยฃ16.24 M-228.6%
2017 -ยฃ12.64 Million-8.98%
2016 -ยฃ13.89 Million-53.79%
2015 -ยฃ30.04 Million-30.18%
2014 -ยฃ43.03 Million173.08%
2013 -ยฃ15.76 Million-25.33%
2012 -ยฃ21.1 Million163.61%
2011 -ยฃ8.01 Million-221.15%
2010 ยฃ6.6 M-124.53%
2009 -ยฃ26.94 Million-29.44%
2008 -ยฃ38.17 Million-36.2%
2007 -ยฃ59.83 Million21.81%
2006 -ยฃ49.12 Million170.55%
2005 -ยฃ18.16 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ19.58 B-14,215.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ11.60 B-8,459.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
ยฃ5.16 B-3,820.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ25.11 B-18,194.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ5.74 B-4,241.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ8.90 B-6,514.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-ยฃ2.1 Million-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA